Close Menu

NEW YORK – Single-cell proteomics firm IsoPlexis said Tuesday that it has received a $2 million Small Business Innovation Research (SBIR) grant from the National Institute on Aging of the National Institutes of Health.

The Phase 2 grant is for work the company is doing to analyze the proteomic responses of trafficking leukocytes in patients with Alzheimer's disease and related neurodegenerative conditions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.

Sep
09
Sponsored by
10x Genomics

Recent advances in spatially resolved transcriptomics have greatly expanded the knowledge of complex multicellular biological systems.